Menopause & perimenopause

Birth control pills in perimenopause — References & further reading

References

¹ Cibula, D., et al. 2010. Hormonal contraception and risk of cancer. Hum. Reprod. Update, 16 (6), 631–650. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/20543200 (accessed 03.24.2011).

  Figueiredo, J., et al. 2010. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: The WECARE Study. Breast Cancer Res. Treat., 120 (1), 175–183. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835545/?tool=pubmed (accessed 03.24.2011).

  Rosenberg, L., et al. 2009. A case-control study of oral contraceptive use and incident breast cancer. Am. J. Epidemiol., 169 (4), 473–479. URL: http://aje.oxfordjournals.org/content/169/4/473.long (accessed 03.24.2011).

  Lee, E., et al. 2007. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: Results from a population-based study. Cancer Epidemiol. Biomarkers Prev., 17 (11), 3170–3178. URL: http://cebp.aacrjournals.org/content/17/11/3170.long (accessed 03.24.2011).

  Brohet, R., et al. 2007. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. J. Clin. Oncol., 25 (25), 3831–3836. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17635951 (accessed 03.24.2011).

  Haile, R., et al. 2006. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol. Biomarkers Prev., 15 (10), 1863–1870. URL: http://cebp.aacrjournals.org/content/15/10/1863.long (accessed 03.24.2011).

  Grenader, T., et al. 2005. BRCA1 and BRCA2 germ-line mutations and oral contraceptives: To use or not to use. Breast, 14 (4), 264–268. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16085232 (accessed 03.24.2011).

  Narod, S., et al. 2002. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J. Natl. Cancer inst., 94 (23), 1773–1779. URL: http://jnci.oxfordjournals.org/content/94/23/1773.long (accessed 03.24.2011).

² Figueiredo, J., et al. 2010.

  Brohet, R., et al. 2007.

  Haile, R., et al. 2006.

  Grenader, T., et al. 2005.

  Narod, S., et al. 2002.

³ Cibula, D., et al. 2010.

  Burkman, R., et al. 2004. Safety concerns and health benefits associated with oral contraception. Am J. Obstet. Gynecol., 190 (4 Suppl.), S5–S22. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15105794 (accessed 03.24.2011).

⁴ Dinger, J., et al. 2010. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: Results from a German case-control study. J. Fam. Plann. Reprod. Health Care, 36 (3), 123–129. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/20659364 (accessed 03.25.2011).

  Sehovic, N., & Smith, K. 2010. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. Ann. Pharmacother., 44 (5), 898–903. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/20371756 (accessed 03.25.2011).

  Frye, C. 2006. An overview of oral contraceptives: Mechanism of action and clinical use. Neurology, 66 (6 Suppl. 3), S29–S36. Review. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16567739 (accessed 03.24.2011).

  Petersen, K. 2002. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Dan. Med. Bull., 49 (1), 43–60. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/11894723 (accessed 03.24.2011).

  Comp, P. 1996. Coagulation and thrombosis with OC use: Physiology and clinical relevance. Dialogues Contracept., 5 (1), 1–3. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/12347721 (accessed 03.24.2011).

⁵ De Groote, D., et al. 2009. Effects of oral contraception with ethinylestradiol and drospirenone on oxidative stress in women 18–35 years old. Contraception, 80 (2), 187–193. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19631796 (accessed 03.25.2011).

  Pincemail, J., et al. 2007.

⁶ [No author or date of publication.] Beyaz (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tables) receives FDA approval. URL: http://www.beyaz.com (accessed 03.30.2011)

⁷ Wallwiener, M., et al. 2010. Effects of sex hormones in oral contraceptives on the female sexual function score: A study in German female medical students. Contraception, 82 (2), 155–159. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/20654756 (accessed 03.25.2011).

  See also: Elton, C. 2010. Study: Low sex drive, ladies? It might be your Pill. Time. URL:http://www.time.com/time/health/article/0,8599,1987870,00.html (accessed 05.10.2010).

⁸ [No authors listed.] 2010. Information from your family doctor. Side effects of hormonal contraceptives. Am. Fam. Physician, 82 (12), 1509. URL: http://www.aafp.org/afp/2010/1215/p1509.html (accessed 03.24.2011).

⁹ Oinonen, k. 2009. Putting a finger on potential predictors of oral contraceptive side effects: 2D:4D and middle-phalangeal hair. Psychoneuroendocrinology, 34 (5), 713–726. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19131172 (accessed 03.24.2011).

¹⁰ Coffee, A., et al. 2008. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives. Pharmacotherapy, 28 (5), 576–583. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/18447656 (accessed 03.24.2011).

  Kurshan, N., & Neill Epperson, C. 2006. Oral contraceptives and mood in women with and without premenstrual dysphoria: A theoretical model. Arch. Women’s Ment. Health, 9 (1), 1–14. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16206030 (accessed 03.24.2011).

¹¹ Kulkarni, J. 2007. Depression as a side effect of the contraceptive pill. Expert Opin. Drug Saf., 6 (4), 371–374. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17688380 (accessed 03.25.2011).

¹² McAndrews, P. [No date of publication.] American Hair Loss Association | Women’s Hair Loss |Oral contraceptives. URL: http://www.americanhairloss.org/women_hair_loss/oral_contraceptives.asp (accessed 03.24.2011).

  Griffiths, W. 1973. Diffuse hair loss and oral contraceptives. Br. J. Dermatol., 88 (1), 31–36. URL (abstract): http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.1973.tb06668.x/abstract (accessed 03.24.2011).

¹³ Burkman, R., et al. 2004.

¹⁴ Thurnham, D., & Northrop–Clewes, C. 1999. Optimal nutrition: Vitamin A and the carotenoids. Proc. Nutr. Soc., 58 (2), 449–457. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/10466190  (accessed 03.24.2011).

  Shojania, A. 1982. Oral contraceptives: Effect of folate and vitamin B12 metabolism. Can. Med. Assoc. J., 126 (3), 244–247. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1862844/?tool=pubmed (accessed 03.25.2011).

  Thurnham, D., & Northrop–Clewes, C. 1999. Optimal nutrition: Vitamin A and the carotenoids. Proc. Nutr. Soc., 58 (2), 449–457. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/10466190 (accessed 03.24.2011).

¹⁵ Shojania, A. 1982. Oral contraceptives: Effect of folate and vitamin B12 metabolism. Can. Med. Assoc. J., 126 (3), 244–247. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1862844/?tool=pubmed (accessed 03.25.2011).

¹⁶ King, J. 1987. Do women using oral contraceptive agents require extra zinc? J. Nutr., 117 (1), 217–219. URL: http://jn.nutrition.org/content/117/1/217.long (accessed 03.25.2011).

¹⁷ Berg, G., et al. 1997. Use of oral contraceptives and serum beta-carotene. Eur. J. Clin. Nutr., 51 (3), 181–187. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/9076409 (accessed 03.25.2011).

¹⁸ Thorp, V. 1980. Effect of oral contraceptive agents on vitamin and mineral requirements. J. Am. Diet. Assoc., 76 (6), 581–584. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/7400487 (accessed 03.25.2011).

  Webb, J. 1980. Nutritional effects of oral contraceptive use: A review. J. Reprod. Med., 25 (4), 150–156. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/7001015 (accessed 03.25.2011).

¹⁹ Kilic, S., et al. 2010. Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment. Gynecol. Endocrinol. [Epub ahead of print.] URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/21105835 (accessed 03.24.2011).

  Lopez, L., et al. 2009. Steroidal contraceptives: Effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst. Rev. (4), CD006133. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19821355 (accessed 03.25.2011).

  Petersen, K. 2002.

 

Additional resources for women

Our Bodies, Ourselves: A New Edition for a New Era, 2005 edition.

From the Boston’s Women’s Health Book Collective.

Women’s Bodies, Women’s Wisdom, by Christiane Northrup, MD.

CDC website for STD’s: http://www.cdc.gov/nchstp/dstd/disease_info.htm#GenInfo

Planned Parenthood website section on STD’s: http://www.plannedparenthood.org/sexual-health/stis-stds-101.htm

Planned Parenthood section on birth control options: http://www.plannedparenthood.org/birth-control-pregnancy/birth-control-4211.htm

Additional resources for practitioners

Contraceptive Technology, 18th Revised edition, by Robert Hatcher, MD. This is a must-have for those working in any facet of women’s health.

Managing Contraceptive Pill Patients, 12th edition, by Richard Dickey, MD. This is “the Dickey pill book” and a must-have for those regularly prescribing and trouble-shooting the pill, patch, or ring.

 

Return to:

BCP’s in perimenopause

 

Last Modified Date: 05/10/2011